Hager Biosciences, LLC
Bethlehem, PA
- UEI
- N3NHX7AYNHN3
- CAGE
- 56S02
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 116 Research Dr #265, Bethlehem, PA 18015, USA
- Website
- hagerbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Experimental therapeutics medicinal chem | Medical Command (Army) | $141,679 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Epigenetix, Inc. | Delray Beach, FL | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Primetime Life Sciences, LLC | Germantown, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
SBA capabilities narrative
Drug Discovery, Medicinal Chemistry, Lead Discovery, Lead Optimization, Synthetic Chemistry, Organic Chemistry, Unique Fragments, Novel Fragments, Building Blocks, Probe Discovery, Focused Library, SAR Optimization, SPR Optimization
Quick answers
Is Hager Biosciences, LLC registered in SAM.gov?
Yes. Hager Biosciences, LLC's SAM.gov registration is active through September 1, 2027.
Which contract vehicles does Hager Biosciences, LLC hold?
Hager Biosciences, LLC holds a place on 1 federal contract vehicle: Experimental Therapeutics Medicinal Chemistry.
What is Hager Biosciences, LLC's most recent federal award?
Hager Biosciences, LLC's most recent federal grant award is Optimization of novel potassium channel KV1.3 blockers with potential as alzheimer's disease therapeutics (R43AG085864), from National Institute on Aging (NIH), on May 15, 2024.
On GovTribe
See Hager Biosciences, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors